Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP803532.RAdON4BKnB6aoLP4c0BTZA4cErrJn0Rsk9bzfBcu2tBuk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP803532.RAdON4BKnB6aoLP4c0BTZA4cErrJn0Rsk9bzfBcu2tBuk130_assertion type Assertion NP803532.RAdON4BKnB6aoLP4c0BTZA4cErrJn0Rsk9bzfBcu2tBuk130_head.
- NP803532.RAdON4BKnB6aoLP4c0BTZA4cErrJn0Rsk9bzfBcu2tBuk130_assertion description "[To study the clinical significance of CK20 expression as a marker of systemic metastatic disease it is essential to measure CK20 mRNA levels in hematopoietic tissue with sensitive quantitative RT-PCR.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP803532.RAdON4BKnB6aoLP4c0BTZA4cErrJn0Rsk9bzfBcu2tBuk130_provenance.
- NP803532.RAdON4BKnB6aoLP4c0BTZA4cErrJn0Rsk9bzfBcu2tBuk130_assertion evidence source_evidence_literature NP803532.RAdON4BKnB6aoLP4c0BTZA4cErrJn0Rsk9bzfBcu2tBuk130_provenance.
- NP803532.RAdON4BKnB6aoLP4c0BTZA4cErrJn0Rsk9bzfBcu2tBuk130_assertion SIO_000772 11074237 NP803532.RAdON4BKnB6aoLP4c0BTZA4cErrJn0Rsk9bzfBcu2tBuk130_provenance.
- NP803532.RAdON4BKnB6aoLP4c0BTZA4cErrJn0Rsk9bzfBcu2tBuk130_assertion wasDerivedFrom befree-20140225 NP803532.RAdON4BKnB6aoLP4c0BTZA4cErrJn0Rsk9bzfBcu2tBuk130_provenance.
- NP803532.RAdON4BKnB6aoLP4c0BTZA4cErrJn0Rsk9bzfBcu2tBuk130_assertion wasGeneratedBy ECO_0000203 NP803532.RAdON4BKnB6aoLP4c0BTZA4cErrJn0Rsk9bzfBcu2tBuk130_provenance.